Antònia Agustí

2.2k total citations
90 papers, 1.2k citations indexed

About

Antònia Agustí is a scholar working on Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health and Economics and Econometrics. According to data from OpenAlex, Antònia Agustí has authored 90 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 16 papers in Pediatrics, Perinatology and Child Health and 16 papers in Economics and Econometrics. Recurrent topics in Antònia Agustí's work include Pharmaceutical studies and practices (14 papers), Pharmaceutical Practices and Patient Outcomes (14 papers) and Pharmacovigilance and Adverse Drug Reactions (13 papers). Antònia Agustí is often cited by papers focused on Pharmaceutical studies and practices (14 papers), Pharmaceutical Practices and Patient Outcomes (14 papers) and Pharmacovigilance and Adverse Drug Reactions (13 papers). Antònia Agustí collaborates with scholars based in Spain, Palestinian Territory and United Kingdom. Antònia Agustí's co-authors include Antonio Vallano, Mercè Obach, Xavier Vidal, Imma Danés, Cristina Aguilera, Consuelo Pedrós, J.M. Arnau, G. García, Françesc Formiga and Alfonso López‐Soto and has published in prestigious journals such as Pharmacological Research, Frontiers in Pharmacology and British Journal of Clinical Pharmacology.

In The Last Decade

Antònia Agustí

80 papers receiving 1.2k citations

Peers

Antònia Agustí

TOXIC

PPCH

CCM

Antonio Vallano Spain

Ghada Miremont‐Salamé France

Kirstin M. Shu United States

Carmen Ferrajolo Italy

A.‐P. Jonville‐Béra France

Hitomi Teramachi Japan

Pascale Olivier France

Stefan Vegter Netherlands

June Raine Netherlands

Cristiano Soares de Moura Canada

Antonio Vallano Spain

Antònia Agustí

230 ×0.7

244 ×0.8

331 ×1.2

TOXIC

300 ×1.3

PPCH

97 ×0.5

CCM

Citations per year, relative to Antònia Agustí Antònia Agustí (= 1×) peers Antonio Vallano

Countries citing papers authored by Antònia Agustí

Since Specialization

Citations

This map shows the geographic impact of Antònia Agustí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antònia Agustí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antònia Agustí more than expected).

Fields of papers citing papers by Antònia Agustí

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antònia Agustí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antònia Agustí. The network helps show where Antònia Agustí may publish in the future.

Co-authorship network of co-authors of Antònia Agustí

This figure shows the co-authorship network connecting the top 25 collaborators of Antònia Agustí. A scholar is included among the top collaborators of Antònia Agustí based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antònia Agustí. Antònia Agustí is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Camacho-Arteaga, Lina, Gloria Iacoboni, Mi Kwon, et al.. (2025). Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma. JAMA Network Open. 8(2). e2461683–e2461683.

Camacho-Arteaga, Lina, Maria Giner‐Soriano, Albert Prats‐Uribe, et al.. (2025). Real-World Data Insights into Antidepressant Prescription and Adherence During Pregnancy in Catalonia (Spain). Drug Safety. 48(12). 1353–1364. 1 indexed citations

Aguilera, Cristina, et al.. (2023). Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system. Frontiers in Pharmacology. 14. 1211786–1211786. 1 indexed citations

Agustí, Antònia, et al.. (2023). Clinical pharmacology facing the real-world setting: Pharmacovigilance, pharmacoepidemiology and the economic evaluation of drugs. Pharmacological Research. 197. 106967–106967. 9 indexed citations

Vallano, Antonio, Caridad Pontes, & Antònia Agustí. (2023). The challenges of access to innovative medicines with limited evidence in the European Union. Frontiers in Pharmacology. 14. 3 indexed citations

Aguilera, Cristina, Imma Danés, Montserrat Bosch, et al.. (2022). Safety of Drugs Used during the First Wave of COVID-19: A Hospital-Registry-Based Study. Diagnostics. 12(7). 1612–1612. 2 indexed citations

Agustí, Antònia, Elena Guillén‐Gómez, Andrés Antón, et al.. (2022). Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial. Enfermedades infecciosas y microbiologia clinica (English ed ). 40(6). 289–295. 1 indexed citations

Agustí, Antònia, Andrés Antón, Cristina Aguilera, et al.. (2020). Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial. Enfermedades Infecciosas y Microbiología Clínica. 40(6). 289–295. 5 indexed citations

Agustí, Antònia, et al.. (2019). Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States. Frontiers in Pharmacology. 10. 921–921. 121 indexed citations

10.

Formiga, Françesc, Xavier Vidal, Antònia Agustí, et al.. (2015). Inappropriate prescribing in elderly people with diabetes admitted to hospital. Diabetic Medicine. 33(5). 655–662. 36 indexed citations

11.

Vallano, Antonio, et al.. (2011). Revisión sistemática de los estudios de evaluación del coste de las reacciones adversas a medicamentos. Gaceta Sanitaria. 26(3). 277–283. 10 indexed citations

12.

Pedrós, Consuelo, Antonio Vallano, Antònia Agustí, et al.. (2009). An Intervention to Improve Spontaneous Adverse Drug Reaction Reporting by Hospital Physicians. Drug Safety. 32(1). 77–83. 70 indexed citations

13.

Berindoague, R., Eduardo M. Targarona, Carmen Balagué, et al.. (2007). Unusual upper gastrointestinal diseases associated with achalasia: laparoscopic approach. Surgical Endoscopy. 21(5). 719–723. 3 indexed citations

14.

Aguilera, Cristina & Antònia Agustí. (2007). Ácido acetilsalicílico en dosis bajas durante el embarazo. Medicina Clínica. 128(1). 31–33.

15.

Agustí, Antònia, et al.. (2006). Novedades en el tratamiento de la insuficiencia cardíaca. Atención Primaria. 38(2). 107–115. 1 indexed citations

16.

Agustí, Antònia & Antonio Vallano. (2006). Gastroprotección y tratamiento con ácido acetilsalicílico a dosis bajas. Medicina Clínica. 126(6). 232–233.

17.

Vallano, Antonio, G. García, Consuelo Pedrós, et al.. (2005). Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. British Journal of Clinical Pharmacology. 60(6). 653–658. 178 indexed citations

18.

Aguilera, Cristina & Antònia Agustí. (2003). Anticoagulación en mujeres embarazadas con prótesis valvulares cardíacas mecánicas. Medicina Clínica. 121(19). 755–756. 1 indexed citations

19.

Agustí, Antònia, et al.. (2003). Interacción entre los inhibidores de la enzima conversiva de la angiotensina y el ácido acetilsalicílico. Medicina Clínica. 121(16). 631–633.

20.

Ferrer, Assumpta, et al.. (1997). From clinical trials to clinical practice: oral anticoagulation among patients with non-rheumatic, atrial fibrillation. European Journal of Clinical Pharmacology. 53(1). 1–5. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact